Pharmaceutical Executive January 20, 2025
Miranda Schmalfuhs

The latest news for pharma industry insiders.

2025 Trends: Leveraging Data Standards

Kimberly Tableman, founder & CEO, ESPERO, discussed the challenges and trends in protocol development for clinical trials. She also highlighted technological advancements, such as data interoperability standards like ICH M11 and CDISC, and how they are expected to streamline protocol development and support generative AI in 2025.

The Good and Bad News About Melanoma

Five-year survival rates improved greatly because of immunotherapy and other advances, according to the American Cancer Society’s annual report on cancer incidence and mortality. But there is a wide gap between how well White patients fare compared to Black patients.

Biden Issues 11th-Hour Cyber Executive Order

Brandishing $102 billion in I.T. purchasing power,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
What’s Driving Pharma Investors in 2025
GoodRx: The Average Price Per Insulin Unit Dropped 42%
Sun Pharma unit poised to buy Canadian biotech Antibe
STAT+: AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug
PBMs Under Fire Again, But Despite Bipartisan Pressure Reforms May Be Elusive

Share This Article